CN128 Tablets

DRUG3 trials

Sponsors

Hangzhou Zede Pharma-Tech Co., Ltd.

Conditions

Iron OverloadThalassemia

Phase 1

Short-term Clinical Study of CN128 in Thalassemia Patients

CompletedNCT03935633

Hangzhou Zede Pharma-Tech Co., Ltd.Thalassemia

Start: 2018-12-03End: 2019-12-17Updated: 2023-06-09

Phase 2

Long-term Clinical Study of CN128 in Thalassemia Patients

CompletedNCT04614779

Hangzhou Zede Pharma-Tech Co., Ltd.Iron Overload, Thalassemia

Start: 2020-09-30End: 2022-08-18Updated: 2023-11-22

Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients

CompletedNCT05355766

Hangzhou Zede Pharma-Tech Co., Ltd.Iron Overload, Thalassemia

Start: 2022-06-13End: 2025-03-06Updated: 2025-03-14